Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Why do we need Active Surveillance? The problem of overdiagnosis, indolent cancer and overtreatment

Date

07 Oct 2016

Session

Active Surveillance for low risk prostate cancer. Session proposed by ESO

Presenters

Monique Roobol

Authors

M. Roobol

Author affiliations

  • Erasmus University Medical Center, Rotterdam/NL
More

Resources

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings